NCT02648178View on ClinicalTrials.gov

Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Nicotine Dependence, Other Tobacco ProductBladder CancerLung CancerCancer of Head and Neck
Interventions
DEVICE

HALO

HALO manufactures e-cigarettes which will be distributed to patients. Two products, the G6 and tank model will be used.

Trial Locations (1)

03756

Dartmouth Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT02648178 - Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers | Biotech Hunter | Biotech Hunter